VERACYTE, INC. Amortization of Debt Discount (Premium)
VERACYTE, INC. (VCYT) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-02-22
- VERACYTE, INC. amortization of debt discount (premium) for the quarter ending 2017-12-31 was $393.00K, a 1303.57% increase year-over-year.
- VERACYTE, INC. amortization of debt discount (premium) for the quarter ending 2017-09-30 was $27.00K, a 0.00% change year-over-year.
- VERACYTE, INC. amortization of debt discount (premium) for the quarter ending 2017-06-30 was $27.00K, a 0.00% change year-over-year.
- VERACYTE, INC. amortization of debt discount (premium) for the quarter ending 2017-03-31 was $26.00K, a 71.43% decline year-over-year.
- VERACYTE, INC. amortization of debt discount (premium) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- VERACYTE, INC. amortization of debt discount (premium) for fiscal 2019 was $107.00K, a 87.72% increase from fiscal 2018.
- VERACYTE, INC. amortization of debt discount (premium) for fiscal 2018 was $57.00K, a 87.92% decline from fiscal 2017.
- VERACYTE, INC. amortization of debt discount (premium) for fiscal 2017 was $472.00K, a 172.83% increase from fiscal 2016.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-22 | |||
| 2019-12-31 | $107.00K 10-K · filed 2021-02-22 | |||
| 2018-12-31 | $57.00K 10-K · filed 2021-02-22 | |||
| 2017-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $420.00K derived: sum of 2 quarters · filed 2020-02-25 | $447.00K derived: sum of 3 quarters · filed 2020-02-25 | $472.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $27.00K 10-Q · filed 2017-11-07 | $54.00K derived: sum of 2 quarters · filed 2017-11-07 | $79.00K 10-Q · filed 2017-11-07 | $108.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $27.00K 10-Q · filed 2017-07-31 | $53.00K 10-Q · filed 2017-07-31 | $81.00K derived: sum of 3 quarters · filed 2019-02-25 | $108.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $26.00K 10-Q · filed 2017-05-03 | $54.00K derived: sum of 2 quarters · filed 2019-02-25 | $81.00K derived: sum of 3 quarters · filed 2019-02-25 | $108.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $55.00K derived: sum of 2 quarters · filed 2019-02-25 | $82.00K derived: sum of 3 quarters · filed 2019-02-25 | $173.00K 10-K · filed 2019-02-25 |
| 2016-09-30 | $27.00K 10-Q · filed 2017-11-07 | $54.00K derived: sum of 2 quarters · filed 2017-11-07 | $145.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $27.00K 10-Q · filed 2017-07-31 | $118.00K 10-Q · filed 2017-07-31 | ||
| 2016-03-31 | $91.00K 10-Q · filed 2017-05-03 | |||
| 2015-12-31 | $46.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |